Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 mice

Carcinogenesis

Volumn 18, Issue 12, 1997, Pages 2421-2427

  Creek, Moire Robertson ^a,c   Mani, Chitra ^a,b   Vogel, John S ^b   Turteltaub, Kenneth W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CARBON 14;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; BLOOD TOXICITY; BONE MARROW; DNA ADDUCT; DNA DETERMINATION; LIVER; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TISSUE DISTRIBUTION;

ANIMALS; BENZENE; BONE MARROW; CARBON RADIOISOTOPES; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER; MALE; MICE; PROTEIN BINDING; TISSUE DISTRIBUTION;

EID: 0031428098     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.12.2421     Document Type: Article

References (30)

1. 1 mice. NIH Publication No. 86-2545, US Department of Health and Human Services, Washington, DC.
2. Maltoni, C., Ciliberti, A., Cotti, G., Conti, B. and Belpoggi, F. (1989) Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ. Health Perspect., 82, 109-124.
3. 1 mice. Environ. Health Perspect., 82, 125-163.
4. Snyder, R. and Kalf, G.F. (1994) A perspective on benzene leukemogenesis. Crit. Rev. Toxicol., 24, 177-209.
5. Perera, F.P. and Weinstein, I.B. (1982) Molecular epidemiology and carcinogen - DNA adduct detection: New approaches to studies on human cancer causation. J. Chron. Dis., 35, 581-600.
6. Poirier, M.C. and Beland, F.A. (1992) DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: Implications for DNA adduct-based human cancer risk assessment. Toxicology, 5, 749-755.
7. Lutz, W.K. (1979) In vivo covalent binding or organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat. Res., 65, 289-356.
8. Oshimura, M. and Barrett, J.C. (1986) Chemically induced aneuploidy in mammalian cells: Mechanisms and biological significance in cancer. Environ. Mol. Mutagen., 8, 129-159.
9. 1 mice treated with benzene. Carcinogenesis, 16, 1803-1808.
10. Mazzullo, M., Bartoli, S., Bonora, B., Colacci, A., Grilli, S., Lattanzi, G., Niero, A., Turina, M.P. and Parodi, S. (1989) Benzene adducts with rat nucleic acids and proteins: Dose - response relationship after treatment in vivo. Environ. Health Perspect., 82, 259-266.
11. Sammett, D., Lee, E.W., Koscis, J.J. and Snyder, R. (1979) Partial hepatectomy reduced both the metabolism and toxicity of benzene. J. Toxicol. Environ. Health, 5, 785-792.
12. 1 mice. Toxicol Appl. Pharmacol., 99, 421-444.
13. Turteltaub, K.W., Felton, J.S., Gledhill, B.L. et al. (1990) Accelerator mass spectrometry in biomedical dosimetry: Relationship between low-level exposure and covalent binding of heterocyclic amine-carcinogens to DNA. Proc. Natl Acad. Sci. USA, 87, 5288-5292.
14. Turteltaub, K.W., Vogel, J.S., Frantz, C.E. and Fultz, E. (1993) Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: A new technique for tracing isotope-labeled DNA adduction. In Phillips, D.H. Castegnaro, M. and Bartsch, H. (eds) Postlabeling Methods for Detection of DNA Adducts. International Agency for Research on Cancer. Lyon, France, pp. 293-301.
15. Vogel, J.S., Turteltaub, K.W., Finkel, R. and Nelson, D.E. (1995) Accelerator mass spectrometry: Isotope identification at attomole sensitivity. Anal. Chem., 67, 353A-359A.
16. Turteltaub, K.W. and Vogel, J.S. (1995) Application of accelerator mass spectrometry in toxicology: A highly sensitive tool for low-level isotope measurements. In Burlingame, A.L. and Carr, S.A. (eds) Mass Spectrometry in the Biological Sciences. Humana Press, Totawa, pp. 477-495.
17. Frantz, C.E., Bangerter, C., Fultz, E., Mayer, K.M., Vogel, J.S. and Turteltaub, K.W. (1995) Dose-response studies of MeIQx in rat liver and liver DNA at low doses. Carcinogenesis, 16, 367-374.
18. Vogel, J.S. (1992) Rapid production of graphite without contamination for biomedical AMS. Radiocarbon, 3, 344-350.
19. Ritschel, W.A. (1980) Hand Book of Basic Pharmacokinetics. Drug Intelligence Publications, Inc., Hamilton, IL, 2nd edn.
20. Wallace, L.A. (1989) The exposure of the general population to benzene. In Mehlman, M.A., (ed.) Benzene: Occupational and Environmental Hazards - Scientific Update. Princeton Scientific Publishing Co., Inc., Princeton, NJ, pp. 113-130.
21. Rickert, D.E., Edgar, T.S., Barrow, C.S., Bus, J. and Irons, R.D. (1979) Benzene disposition in rats after inhalation exposure. Toxicol. Appl. Pharmacol., 49, 417-423.
22. 32P Analysis of DNA adducts in tissues of benzene-treated rats. Environ. Health Perspect., 82, 253-257.
23. 1 mice treated with benzene: Implications for molecular dosimetry. Environ. Health Perspect., 104, 1189-1193.
24. 32P-postlabeling with the DNA adduct formed in HL-60 cells treated with hydroquinone. Chem. Res. Toxicol., 9, 593-598.
25. Dean, B.J. (1985) Recent findings on the genetic toxicology of benzene, toluene, xylenes and phenols. Mutat. Res., 154, 153-181.
26. Yager, J.W., Eastmond, D.A., Robertson, M.L., Paradisin, W.M. and Smith, M.T. (1990) Characterization of micronuclei induced in human lymphocytes by benzene metabolites. Cancer Res., 50, 393-399.
27. Zhang, L., Venkatesh, P., Robertson-Creek, M.L. and Smith, M.T. (1994) Detection of 1,2,4-benzenetriol induced aneuploidy and microtubule disruption by fluorescent in situ hybridization and immunocytochemistry. Mutat. Res., 320, 315-327.
28. 6]benzene to rats. Carcinogenesis, 14, 1921-1925.
29. 6]benzene. Cancer Res., 54, 4907-4914.
30. Travis, C.C. and Bowers, J.C. (1989) Protein binding of benzene under ambient exposure conditions. Toxicol. Ind. Health, 5, 1017-1024.